Reuters logo
9 天前
BRIEF-Alnylam Pharmaceuticals reports Q2 adj loss per share $1.07
2017年8月9日 / 晚上8点08分 / 9 天前

BRIEF-Alnylam Pharmaceuticals reports Q2 adj loss per share $1.07

Aug 10 (Reuters) - Alnylam Pharmaceuticals Inc-

* Alnylam Pharmaceuticals reports second quarter 2017 financial results and highlights recent period activity

* Q2 non-gaap loss per share $1.07

* Q2 revenue $15.9 million versus $8.7 million

* Q2 revenue view $22.3 million -- Thomson Reuters I/B/E/S

* Q2 earnings per share view $-1.22 -- Thomson Reuters I/B/E/S

* Alnylam Pharmaceuticals Inc - remains on track to end 2017 with greater than $1.0 billion in cash, cash equivalents and fixed marketable securities

* Q2 earnings per share view $-1.22, revenue view $22.3 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below